Accenture Invests in QuantHealth to Accelerate Use of AI-powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

2 years ago

NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Accenture (NYSE: ACN) announced it has made a strategic investment, through Accenture Ventures, in…

Axonics Announces Definitive Agreement to be Acquired by Boston Scientific

2 years ago

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that it has entered into a definitive agreement to be acquired by…

Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue

2 years ago

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the…

BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update

2 years ago

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:…

Izotropic Provides Regulatory and Operational Updates

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - January 8, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the…

MentalHealth.com Acquires Online Mental Health Platform and Community

2 years ago

SAN FRANCISCO, CA / ACCESSWIRE / January 8, 2024 / Leading patient-first health technology company MentalHealth.com is pleased to announce…

Tryp Therapeutics Announces Significant Milestone in Its Clinical Trial Program for Trp-8803 (IV-infused Psilocin)

2 years ago

KELOWNA BC / ACCESSWIRE / January 8, 2024 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP)(OTCQB:TRYPF), a pioneering clinical-stage…

Moderna Provides Business and Pipeline Updates at 42nd Annual J.P. Morgan Healthcare Conference

2 years ago

Company announces product sales for 2023 of approximately $6.7 billion (unaudited); U.S. COVID-19 market share season to date increased to…

PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance

2 years ago

PharmAla to present its intellectual property assets to potential partners at the annual JPM healthcare conference on January 8-11th in…

GeneDx Announces Preliminary 2023 Financial Results

2 years ago

Expects to exceed revised 2023 revenue guidance with fourth quarter 2023 revenue from continuing operations1 of more than $57M with…